What the company does
Inbiogen distributes self-service kiosk terminals, the standalone touchscreen machines used for unattended payments and ordering, and operates a food-and-beverage business.
Its kiosk products serve businesses and venues that want to automate customer transactions without a cashier. The company is listed on KOSPI, South Korea's main stock exchange, and is classified as a small and medium-sized enterprise under Korean regulations. Its two business lines, kiosk distribution and food and beverage, form the entirety of its current operations.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue · FY2025
US$4.6M
▼ −10.6% YoY
Operating profit · FY2025
−US$3.1M
Loss narrowed
Net income · FY2025
−US$1M
Turned to loss
Revenue
- FY2023US$4.5M
- FY2024US$5.1M
- FY2025US$4.6M
Operating profit
- FY2023−US$4.5M
- FY2024−US$4.4M
- FY2025−US$3.1M
Net income
- FY2023US$8.2M
- FY2024US$11.7M
- FY2025−US$1M
Key ratios (FY2025)
ROE
-0.9%
Debt/Eq
1.5%
Op. margin
-68.8%
Net margin
-22.5%
Rev. YoY
▼ −10.6%
Price charts coming soon
Interactive price history isn't here yet. Would you use it?